409 related articles for article (PubMed ID: 22722776)
1. Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.
Neely MN; van Guilder MG; Yamada WM; Schumitzky A; Jelliffe RW
Ther Drug Monit; 2012 Aug; 34(4):467-76. PubMed ID: 22722776
[TBL] [Abstract][Full Text] [Related]
2. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
3. Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian.
Tatarinova T; Neely M; Bartroff J; van Guilder M; Yamada W; Bayard D; Jelliffe R; Leary R; Chubatiuk A; Schumitzky A
J Pharmacokinet Pharmacodyn; 2013 Apr; 40(2):189-99. PubMed ID: 23404393
[TBL] [Abstract][Full Text] [Related]
4. A population pharmacokinetic model of gabapentin developed in nonparametric adaptive grid and nonlinear mixed effects modeling.
Carlsson KC; van de Schootbrugge M; Eriksen HO; Moberg ER; Karlsson MO; Hoem NO
Ther Drug Monit; 2009 Feb; 31(1):86-94. PubMed ID: 19077930
[TBL] [Abstract][Full Text] [Related]
5. The influence of sparse data sampling on population pharmacokinetics: a post hoc analysis of a pharmacokinetic study of morphine in healthy volunteers.
Ariano RE; Duke PC; Sitar DS
Clin Ther; 2012 Mar; 34(3):668-76. PubMed ID: 22381713
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches.
Prémaud A; Weber LT; Tönshoff B; Armstrong VW; Oellerich M; Urien S; Marquet P; Rousseau A
Pharmacol Res; 2011 Mar; 63(3):216-24. PubMed ID: 21056671
[TBL] [Abstract][Full Text] [Related]
7. Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers.
Wedagedera JR; Afuape A; Chirumamilla SK; Momiji H; Leary R; Dunlavey M; Matthews R; Abduljalil K; Jamei M; Bois FY
CPT Pharmacometrics Syst Pharmacol; 2022 Jun; 11(6):755-765. PubMed ID: 35385609
[TBL] [Abstract][Full Text] [Related]
8. Nonparametric Methods in Population Pharmacokinetics.
Goutelle S; Woillard JB; Neely M; Yamada W; Bourguignon L
J Clin Pharmacol; 2022 Feb; 62(2):142-157. PubMed ID: 33103785
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategy.
Vinks AA; Mouton JW; Touw DJ; Heijerman HG; Danhof M; Bakker W
Antimicrob Agents Chemother; 1996 May; 40(5):1091-7. PubMed ID: 8723446
[TBL] [Abstract][Full Text] [Related]
10. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of centhaquin citrate in a dog model.
O'Donnell JN; O'Donnell EP; Kumar EJ; Lavhale MS; Andurkar SV; Gulati A; Scheetz MH
J Pharm Pharmacol; 2016 Jun; 68(6):803-9. PubMed ID: 27109141
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of ethanol in drinking drivers using breath measures.
Clardy DO
Ther Drug Monit; 2004 Aug; 26(4):391-400. PubMed ID: 15257069
[TBL] [Abstract][Full Text] [Related]
13. CYP2B6 Genotype Guided Dosing of Propofol Anesthesia in the Elderly based on Nonparametric Population Pharmacokinetic Modeling and Simulations.
Eugene AR
Int J Clin Pharmacol Toxicol; 2017; 6(1):242-249. PubMed ID: 28154789
[TBL] [Abstract][Full Text] [Related]
14. Bayesian nonparametric population models: formulation and comparison with likelihood approaches.
Wakefield J; Walker S
J Pharmacokinet Biopharm; 1997 Apr; 25(2):235-53. PubMed ID: 9408861
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.
Jelliffe R; Schumitzky A; Van Guilder M
Ther Drug Monit; 2000 Jun; 22(3):354-65. PubMed ID: 10850405
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic modelling of tramadol with application of the NPEM algorithms.
Gan SH; Ismail R; Wan Adnan WA; Zulmi W; Jelliffe RW
J Clin Pharm Ther; 2004 Oct; 29(5):455-63. PubMed ID: 15482390
[TBL] [Abstract][Full Text] [Related]
17. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics.
Dodds MG; Vicini P
Ann Biomed Eng; 2004 Sep; 32(9):1300-13. PubMed ID: 15493516
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
19. Optimization of mycophenolic acid therapy using clinical pharmacometrics.
Dong M; Fukuda T; Vinks AA
Drug Metab Pharmacokinet; 2014; 29(1):4-11. PubMed ID: 24351871
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients.
Woillard JB; Debord J; Monchaud C; Saint-Marcoux F; Marquet P
Clin Pharmacokinet; 2017 Dec; 56(12):1491-1498. PubMed ID: 28389935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
